Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Facing death, returning to life

A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness

Bibliographic Data

ID15529210
AuthorsWilliam P Barone (0000-0002-5108-0149, corresponding author), William Barone, Michiko Mitsunaga-Whitten (Behavior Therapy Associates), Lia Osunfunláyò Blaustein (John F. Kennedy University), Phillip Perl (0000-0001-5854-1502, Public Service Electric and Gas (United States)), Marisa Swank (University of Essex), Thomas Cody Swift (Johns Hopkins Medicine)
Year2022
Volume13
Pages944849-944849
Publication date2022-09-27
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2022.944849
PMID36238946
OpenAlexW4297173008
LanguageEN
Citations received4
References cited36

Anxiety associated with life-threatening illness (LTI) is a pervasive mental health issue with a wide impact. A spectrum of traditional pharmacotherapies and psychotherapies are available, but offer varying success in reducing symptoms and improving quality of life. We explore a novel therapy for this condition by assessing prominent thematic elements from participant narrative accounts of a pilot phase 2 clinical trial of 3,4 Methylenedioxymethamphetamine-Assisted Therapy (MDMA-AT) for treating anxiety associated with LTI. Semi-structured qualitative interviews were conducted with a subset of adult participants 3 months following completion of this trial. This qualitative analysis sought to complement, clarify, and expand upon the quantitative findings obtained from the clinical trial to further understand the process and outcomes of the treatment. Interviews were coded and analyzed using an Interpretative Phenomenological Analysis (IPA) methodological framework. Participants described in detail their experiences from before, during and after the trial, which were analyzed and categorized into thematic clusters. Specifically, participants explored what they felt were important elements of the therapeutic process including processing trauma and grief, exploring mystical and existential experiences, engaging with the present moment with reduced physiological activation, and facing illness and existential fears. Outcomes of the treatment included increased ability to cope with LTI, reduced psychological symptoms, improved vitality and quality of life, and feeling more resourced. Participant narratives also showed a reconnection to life and greater emotional resilience in response to trauma and medical relapse. These findings are compared to similar treatments for the same indication. Limitations and challenges encountered in conducting this study are discussed along with implications for theory and clinical treatment

Anxiety · Feeling · Grief · Interpretative phenomenological analysis · Psychiatry · Psychotherapist · Qualitative research · Quality of life (healthcare · Thematic analysis · Vitality · Cannabis and Cannabinoid Research · Clinical Psychology · Complementary and Alternative Medicine Studies · Medicine · Psychedelics and Drug Studies · Psychology · Social Psychology

  • Memory, trauma, and self

    Open Access•J R Rose•Journal of Psychedelic Studies•2024

  • The mushroom was more alive and vibrant

    Open Access•Pamela Kryskow, Paul Stamets et al.•Journal of Psychedelic Studies•2024

  • A scoping review of variations among psychedelic interventions for psychological suffering associated with the end of life

    Open Access•Sarah Kratina, Carol Strike et al.•Social Science & Medicine•2025

  • Acute Subjective Effects of Psychedelics within and Beyond Weird Contexts

    Mariolina Graziosi, Manvir Singh et al.•Journal of Psychoactive Drugs•2023

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Journal of Psychopharmacology•2016

  • The Body Keeps the Score

    Bessel A van der Kolk•Harvard Review of Psychiatry•1994

  • Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

    Open Access•Leor Roseman, David Nutt et al.•Frontiers in Pharmacology•2018

  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

    Open Access•Katherine A Maclean, Matthew W Johnson et al.•Journal of Psychopharmacology•2011

  • MDMA-assisted therapy for severe PTSD

    Open Access•Jennifer M Mitchell, Michael P Bogenschutz et al.•Nature Medicine•2021

  • Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

    Charles S Grob, Alicia Danforth et al.•Archives of General Psychiatry•2011

  • Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer

    Open Access•Stephen Ro, Stephen Ross et al.•Journal of Psychopharmacology•2016

  • Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

    Open Access•RR Griffiths, R R Griffiths et al.•Journal of Psychopharmacology•2008

  • Family caregiver burden

    Open Access•Eva Grunfeld•Canadian Medical Association…•2004

  • Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

    Open Access•Peter Gasser, Dominique Holstein et al.•The Journal of Nervous and Mental…•2014

  • Using multiple coders to enhance qualitative analysis

    Lynda Berends, Jennifer Johnston•Addiction Research & Theory•2005

  • Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner

    Michael Lyvers, Molly Meester•Journal of Psychoactive Drugs•2012

  • Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction

    William P Barone, William Barone et al.•Journal of Psychoactive Drugs•2019

  • Interpretative Phenomenological Analysis (IPA)

    Deborah Biggerstaff, Alan Reynolds Thompson•Qualitative Research in Psychology•2008

  • MDMA-Assisted Therapy for Posttraumatic Stress Disorder

    Open Access•Terence H W Ching, M T Williams et al.•Journal of Humanistic Psychology•2024

  • Patient Experiences of Psilocybin-Assisted Psychotherapy

    Open Access•Alexander Belser, Alexander B Belser et al.•Journal of Humanistic Psychology•2017

  • Cancer at the Dinner Table

    Open Access•Thomas Cody Swift, Alexander Belser et al.•Journal of Humanistic Psychology•2017

  • Sample Size in Qualitative Interview Studies

    Open Access•Kirsti Malterud, Volkert Dirk Siersma et al.•Qualitative Health Research•2016

Unique citing works4
Citations per year1,33
Citation span2023 - 2025 (3)
Citation velocityrecent
Highly citedNo
Citation typesNeutral: 4

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae